NEW YORK (GenomeWeb News) – Horizon Diagnostics, a division of Cambridge, UK-based Horizon Discovery, said today that it will collaborate with the UK National External Quality Assessment Service on genetically defined reference standards for novel lung cancer biomarkers.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.